Mie University · Graduate School of Medical Sciences

Research keywordsleukemogenesis・hematologic malignancies・MLL fusion・PLZF-RARA・hematopoietic stem cells・diffuse large B-cell lymphoma

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• 1. Ono R, Masuya M,Inoue N, Shinmei M, Ishii S, Maegawa Y, Maharjan BD, Katayama N, Nosaka T. Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models. PLoS One. 16:e0248425, 2021.2021 · 主な業績等
• 1. Sawaki A, Miyazaki K, Yamaguchi M, Takeuchi T, Kobayashi K, Imai H, Tawara I, Ono R, Nosaka T, Katayama N. Genetic polymorphisms and vincristine-induced peripheral neuropathy in patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone therapy. Int J Hematol. 111: 686-691, 2020.2020 · 主な業績等
• 1. 小埜良一、野阪哲哉. 血液腫瘍モデル動物の現状と展望. 日本臨床 78巻増刊3: 152-158, 2020.2020 · 主な業績等
• 1. Maharjan BD, Ono R, Nosaka T. Eya2 is critical for the E2A-HLF-mediated immortalization of mouse hematopoietic stem/progenitor cells. Int J Oncol. 54:981-990, 2019.2019 · 主な業績等

• Official profile